As of 2024-12-12, the Intrinsic Value of Amedisys Inc (AMED) is
117.78 USD. This Amedisys valuation is based on the model Discounted Cash Flows (Growth Exit 5Y).
With the current market price of 85.53 USD, the upside of Amedisys Inc is
37.70%.
The range of the Intrinsic Value is 82.26 - 208.22 USD
117.78 USD
Intrinsic Value
Amedisys Intrinsic Value - Valuation Summary
|
Range |
Selected |
Upside |
| a |
| DCF (Growth 5y) |
82.26 - 208.22 |
117.78 |
37.7% |
| DCF (Growth 10y) |
127.57 - 314.83 |
180.71 |
111.3% |
| DCF (EBITDA 5y) |
115.38 - 174.43 |
143.10 |
67.3% |
| DCF (EBITDA 10y) |
161.97 - 262.72 |
206.93 |
141.9% |
| Fair Value |
12.66 - 12.66 |
12.66 |
-85.20% |
| P/E |
56.46 - 81.03 |
69.59 |
-18.6% |
| EV/EBITDA |
61.10 - 120.93 |
85.43 |
-0.1% |
| EPV |
60.06 - 92.31 |
76.18 |
-10.9% |
| DDM - Stable |
18.95 - 60.62 |
39.79 |
-53.5% |
| DDM - Multi |
62.01 - 158.49 |
89.65 |
4.8% |
Amedisys Intrinsic Value - Key Valuation Metrics
| Market Cap (mil) |
2,801.11 |
| Beta |
0.44 |
| Outstanding shares (mil) |
32.75 |
| Enterprise Value (mil) |
2,937.56 |
| Market risk premium |
4.60% |
| Cost of Equity |
8.56% |
| Cost of Debt |
4.73% |
| WACC |
7.94% |